[Federal Register Volume 59, Number 191 (Tuesday, October 4, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-24474]


[[Page Unknown]]

[Federal Register: October 4, 1994]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary
[GN# 2275]

 

Notice of Three Meetings of the Commission on Research Integrity

    Pursuant to P.L. 92-463, notice is hereby given of three future 
meetings of the Commission on Research Integrity. Meetings are subject 
to availability of funds and interested parties are advised to call the 
Executive Secretary shortly before scheduled meetings to verify each 
date and place. The meetings are planned as follows:
     Wednesday, October 19th, from 9 a.m. to 5 p.m. at the 
Stouffer Concourse Hotel, James Room, 2399 Jefferson Davis Highway, 
Arlington, VA 22202. The Commission invites respondents in alleged 
misconduct cases and attorneys who have advised them to present their 
views in person or in writing on the strengths and weaknesses of the 
way institutions and the Public Health Service (PHS) pursue such 
allegations. The Commission will also continue to discuss definitions 
of research misconduct.
     Monday, November 7th, from 8:30 a.m. to 4:30 p.m. at the 
National Institutes of Health, 9500 Rockville Pike, Building 31, 
Conference Room 6, Bethesda, MD 20892. The Commission is planning a 
dialogue with the Director, NIH, and other intramural and extramural 
officials and employees on the strengths and weaknesses of the present 
PHS system of pursuing scientific misconduct.
     Thursday, December 1st, from 9 a.m. to 5 p.m. and on 
Friday, December 2nd, from 8 a.m. to 3 p.m. at the Stouffer Concourse 
Hotel, Potomac Room, 2399 Jefferson Davis Highway, Arlington, VA 22202. 
On the first day, the Commission invites whistleblowers and witnesses 
in alleged scientific misconduct cases and counsel who have advised 
them to present their views in person or in writing on the strengths 
and weaknesses of the way the PHS and institutions pursue such 
allegations. On the second day, the Commission will continue its 
discussion of specific issues in scientific misconduct and the 
responsible conduct of research.
    The mandate of the Commission is to develop recommendations for the 
Secretary of Health and Human Services and the Congress on the 
administration of Section 493 of the PHS Act, as amended by and added 
to, by Section 161 of the NIH Revitalization Act of 1993. Discussion 
items may include but will not be limited to the issues noted above.
    Henrietta D. Hyatt-Knorr, Executive Secretary, Commission on 
Research Integrity, at the Office of Research Integrity, Division of 
Policy and Education, Rockwall II, Suite 700, 5515 Security Lane, 
Rockville MD 20852, (301) 443-5300, will furnish meeting agendas, the 
Committee charter, and a roster of the Committee members upon request. 
Persons wishing to make presentations should contact the Executive 
Secretary. Depending on the number of oral presentations and other 
considerations, the Executive Secretary will allocate a reasonable 
timeframe for each speaker.
    Commission members will prepare questions to guide witnesses in 
their presentations. The questions should be obtained from the 
Executive Secretary. More detailed statements from witnesses on their 
individual experiences may be submitted in writing to the Executive 
Secretary before or at the meeting. Each statement will be reviewed by 
Commission Members. Witnesses and members of the public are advised 
that in both written or oral statements presented to the Commission, 
they should not reveal any confidential information from any open case 
under investigation by an institution or the Office of Research 
Integrity or from any closed case where there has not been a finding of 
scientific misconduct or which has not otherwise been made public.

    Dated: September 27, 1994.
Lyle W. Bivens,
Director, Office of Research Integrity
[FR Doc. 94-24474 Filed 10-3-94; 8:45 am]
BILLING CODE 4160-17-M